Madrigal pharmaceuticals announces participation at two upcoming virtual investor conferences

Conshohocken, pa., nov. 23, 2021 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq: mdgl), a clinical-stage biopharmaceutical company pursuing novel therapeutics for cardio-metabolic and fatty liver diseases with high unmet medical need such as non-alcoholic steatohepatitis (nash), announced today its management team will participate in two upcoming virtual investor conferences:
MDGL Ratings Summary
MDGL Quant Ranking